Stock Events

Stock Events

Atrium Therapeutics (RNA) Q3 2024 Earnings

9AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-0.8

-0.75

-0.7

-0.65

Details

Expected EPS

-0.756188

Actual EPS

-0.65

Surprise EPS

0.11

Surprise Percent

+14.04%

Description

Atrium Therapeutics (RNA) has reported earnings of -0.65 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.